Drug interactions
Liposomal doxorubicin + Oxcarbazepine
Severity: Minor
Liposomal doxorubicin and Oxcarbazepine: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Oxcarbazepine is a weak inducer of CYP3A4 and could modestly lower exposure to doxorubicin. Reduced anthracycline exposure might blunt antitumor activity, but the effect is expected to be small and is mostly theoretical.
What this interaction means in plain words
Liposomal doxorubicin and Oxcarbazepine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Liposomal doxorubicin belongs to Oncology; Oxcarbazepine belongs to Central Nervous System.
Why it happens
Weak CYP3A4 induction by oxcarbazepine may slightly increase doxorubicin clearance; CYP3A4 is only a minor elimination route for doxorubicin.
What to do
No routine dose change is needed; monitor tumor response and consider a non-inducing anticonvulsant such as levetiracetam if seizure control allows.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Liposomal doxorubicin and Oxcarbazepine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Liposomal doxorubicin
- Dengue vaccine + Liposomal doxorubicin Contraindicated
- Belatacept + Liposomal doxorubicin Major
- Cyclosporine + Liposomal doxorubicin Major
- Dronedarone + Liposomal doxorubicin Major
- Elvitegravir / cobicistat / emtricitabine / tenofovir df + Liposomal doxorubicin Major
- Fingolimod + Liposomal doxorubicin Major
Other interactions of Oxcarbazepine
- Cabotegravir + Oxcarbazepine Contraindicated
- Oxcarbazepine + Rilpivirine Contraindicated
- Artemether / lumefantrine + Oxcarbazepine Major
- Atazanavir + Oxcarbazepine Major
- Benzhydrocodone / acetaminophen + Oxcarbazepine Major
- Bictegravir + Oxcarbazepine Major
Frequently asked questions
Can I take Liposomal doxorubicin with Oxcarbazepine?
MediHelp rates the interaction as minor. Liposomal doxorubicin and Oxcarbazepine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Oxcarbazepine is a weak inducer of CYP3A4 and could modestly lower exposure to doxorubicin. Reduced anthracycline exposure might blunt antitumor activity, but the effect is expected to be small and is mostly theoretical.
How serious is the interaction between Liposomal doxorubicin and Oxcarbazepine?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; monitor tumor response and consider a non-inducing anticonvulsant such as levetiracetam if seizure control allows.
What other medicines interact with Liposomal doxorubicin?
MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Belatacept, Cyclosporine. The full list is on the Liposomal doxorubicin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
